My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: New Mexico cancel Opioids cancel

Harm Reduction Policies Can Prevent Overdose Fatalities

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Opioids,
Overdose Prevention,
Oklahoma,
Alabama,
Connecticut,
Georgia,
Louisiana,
Minnesota,
Nevada,
New Mexico,
Tennessee,
West Virginia,
Wisconsin,
Arkansas,
Delaware,
Illinois,
Maryland,
Massachusetts,
Missouri,
Rhode Island,
Washington,
New York,
California,
Vermont,
JoAnne McClure

Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e

The Role of Syringe Services Programs in New Mexico’s Opioid Crisis Response

Brief,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Infectious Disease,
Opioids,
New Mexico,
Syndemic-Related Infections

This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use drugs. New Mexico’s success in leveraging ...

2023 Legislative Session Update: Part One

Blog,
Health Policy Update,
Policy,
State Health Policy,
Territorial Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
STIs,
HIV,
Substance Misuse,
Opioids,
Tobacco Control,
Environmental Health,
Food and Water Safety,
PFAS,
Florida,
Guam,
Hawaii,
Illinois,
Indiana,
Kentucky,
Mississippi,
New Mexico,
New York,
Oklahoma,
South Dakota,
Utah,
Vermont,
Virginia,
West Virginia,
Beth Giambrone,
Christina Severin,
Parker Beene,
Maggie Davis

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.